Federal prosecutors in Massachusetts say British drug maker GlaxoSmithKline PLC will pay $750 million to settle allegations that its subsidiary manufactured and sold adulterated drugs, including the popular antidepressant Paxil.
U.S. Atty. Carmen Ortiz on Tuesday announced that GlaxoSmithKline has agreed to settle civil and criminal charges related to the subsidiary in Puerto Rico. Get the full story »
